Early Phase 1 Pancreatitis Trial, Recruiting NCT05664880 Sponsor: Cedars-Sinai Medical Center Condition: Pancreatitis
Back to Pancreatitis

Early Phase 1 Pancreatitis Trial, Recruiting

NCT05664880
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 75 years old
  • You have been diagnosed with chronic pancreatitis that was not caused by gallstones, medications, injury, or an autoimmune condition
  • You are able to swallow pills and are willing to take them as directed throughout the study
  • Your blood calcium, phosphate, and parathyroid hormone levels are all within the normal range
  • You have not had any surgery on your pancreas before
  • If you have pancreatic tissue death (necrosis), it affects less than half of the pancreas (confirmed by a radiologist)
  • You are not currently in another clinical trial and have not been in one within the last 6 months
  • You are willing to sign a consent form and take part in all study activities for the full length of the study
  • If you could become pregnant, you agree to use a reliable form of birth control for at least one month before the study starts, throughout the study, and for one week after finishing the study treatment
  • If you are male and could father a child, you agree to use condoms or another reliable method of contraception with your partner

Who may not be able to join:

  • You are currently pregnant or breastfeeding
  • You have a history of pancreatitis caused by an autoimmune condition or injury, or a severe episode of pancreatitis that may have damaged the ducts in your pancreas
  • You have a known tumor of the pancreas (such as pancreatic cancer, certain cysts larger than 1 cm, or other pancreatic tumors)
  • Cancer from another part of your body has spread to your pancreas
  • You have had an organ transplant or have HIV/AIDS
  • Your blood calcium, phosphate, or parathyroid hormone levels are outside the normal range
  • You have a known condition where your pancreas does not produce enough digestive enzymes, but you do not meet the other requirements to join the study (confirm with trial site)
  • You have a physical illness, mental health condition, or ongoing substance use problem that the study doctor feels would make it difficult for you to safely take part in the study
  • Your kidneys are not working well enough — specifically, if your kidney function level (GFR) is below 30 (confirm with trial site)
  • You are currently in prison or jail
  • You are unable to have an MRI scan
  • If you could become pregnant (unless you are post-menopausal, have had a hysterectomy, or have had a sterilisation procedure), you must have a negative pregnancy test within 2 days before any research-related procedures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: Stephen Pandol, MD, Cedars-Sinai Medical Center

Phone: 3109671110

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Sponsor
Cedars-Sinai Medical Center
Registry
ClinicalTrials.gov
Start date
1 June 2023
Est. completion
1 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Examine the feasibility of testing the effect of paricalcitol on health-related quality of life in patients with chronic pancreatitis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov